Continued Quality Push Among China's 2016 Regulatory Trends To Watch
This article was originally published in The Tan Sheet
The China pharma market in 2015 was marked by a drastic market slowdown and turbulent regulatory headwinds. But looking ahead, analysts say while challenges remain, some important breakthroughs could be on the way.
Register for our free email digests: